This course provides an in-depth study of the pharmaceutical industry from target identification through preclinical development. In addition to lectures led by the instructor and several guest lecturers, students will participate on project teams to evaluate a potential drug target, and then advance the project through lead discovery, lead optimization and preclinical development to the IND stage. Students will participate in a series of group presentations where project teams will discuss how they dealt with real-life problems encountered by drug discovery and development teams and assemble a summary IND document.
The Master of Business & Science degree at Rutgers is a hybrid degree combining courses from an MS in a science area and business courses. This program is a part of the Rutgers Graduate School - New Brunswick.